Evotec SE

Comment on media report

Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

Evotec SE to announce results for the first nine months 2024 on 06 November 2024

Evotec and Bristol Myers Squibb expand proteomics partnership

Evotec SE: Laetitia Rouxel, Restricted shares granted as Short-Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system

Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies

Just – Evotec Biologics opens cutting-edge biologics facility – J.POD® Toulouse, France (EU)

Evotec SE: Dr. Christian Wojczewski, buy

Evotec SE: Aurélie Dalbiez, buy

Evotec announces change in Management Board

Evotec SE: Dr. Christian Wojczewski, buy

Evotec SE: Prof. Dr. Iris Löw-Friedrich, buy

Evotec SE: Dr. Christian Wojczewski, buy

Evotec SE: Dr. Craig Johnstone, buy

Evotec SE: Dr. Christian Wojczewski, buy

Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths

Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb

Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb

Evotec SE reports first half-year 2024 results on 14 August 2024